Skip to main content

Featured

GD, HK boost IP co-operation

Guangdong and Hong Kong today endorsed the co-operation projects on intellectual property (IP) rights protection from mid-2022 to the end of 2023.   The Guangdong/Hong Kong Expert Group on the Protection of Intellectual Property Rights agreed to continue to strengthen the mutual collaboration and development of IP between Guangdong and Hong Kong.   The group’s co-operation projects cover areas such as reinforcing co-operation on IP in the Greater Bay Area, and promoting co-operation on IP protection, trading and services, exchange as well as promotion and education activities in both places.   On cross-boundary IP protection, customs authorities in both places will focus on copyright protection on the Internet, and both sides will strengthen co-operation in and exchanges of copyright enforcement.   In 2020, the expert group formulated an annual co-operation plan and extended its implementation in light of the pandemic situation. Over the past two years, group members have imple

Hong Kong Science Park: Healthy ecosystem cultivates powerful global collaboration

(English) A healthy ecosystem cultivates powerful global collaboration
 
BeiGene, a global commercial-stage biotech company, has entered a worldwide strategic collaboration with our park company InnoRNA to take mRNA-based therapeutics to the next level. bit.ly/3yW8S0f

You probably heard about Messenger RNA (mRNA). It has been used in some of the leading COVID vaccines.

Q: What's mRNA's superpower?
A: It directs human cells to generate proteins to help our immune systems develop antibodies for disease prevention and treatment.

Q: What's InnoRNA's superpower?
A: The platform developed by CEO Dr Li Linxian makes the mRNA less fragile, and the technology can rapidly and accurately identify safe and effective mRNA carriers for clinical treatment.

Q: What's HKSTP's superpower?
A: Hong Kong is the world's number two biotech funding hub.  We will leave you to find out more!

Follow our page for more biotech news in Hong Kong and beyond.

 
 

Popular Posts